Thus, a positive feedback loop between local inflammation in adipose tissue and altered immune response in obesity, may contribute to the development of obesity-related metabolic complications and the inhibition of NF-kB signalling pathways could be an excellent strategy for treatment of metabolic complications in obese individuals. Here, NFKB1 is linked to Obesity.